(Q45229513)

English

Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage

scientific article published on 23 June 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Francesca Ceccherini-Silberstein

5

object named as

Francesca Ceccherini-Silberstein

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Salvatore Dimonte

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Muhammed Babakir-Mina

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Fabio Mercurio

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Domenico Di Pinto

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Valentina Svicher

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Carlo-Federico Perno

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

23 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

168

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

73-83

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Is HIV-1 evolving to a less virulent form in humans?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

A new classification for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

HIV-2 A-subtype gp125c₂-v₃-c₃ mutations and their association with CCR5 and CXCR4 tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Mechanisms of viral membrane fusion and its inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

All-atom models of the membrane-spanning domain of HIV-1 gp41 from metadynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

V3: HIV's switch-hitter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Global trends in molecular epidemiology of HIV-1 during 2000-2007.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Structure of a V3-containing HIV-1 gp120 core

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Maraviroc, a CCR5 coreceptor antagonist that blocks entry of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Regulation of N-linked core glycosylation: use of a site-directed mutagenesis approach to identify Asn-Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Selective pressures of human immunodeficiency virus type 1 (HIV-1) during pediatric infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

HIV-1 subtype C in vitro growth and coreceptor utilization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Robust supervised and unsupervised statistical learning for HIV type 1 coreceptor usage analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Sphingolipids: modulators of HIV-1 infection and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Association of enhanced HIV-1 neutralization by a single Y681H substitution in gp41 with increased gp120-CD4 interaction and macrophage infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Dynamics of Syncytium-Inducing and Non-Syncytium-Inducing Type 1 Human Immunodeficiency Viruses during Primary Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Maraviroc: a new CCR5 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Structural Characterization of HIV gp41 with the Membrane-proximal External Region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Topology of the C-terminal tail of HIV-1 gp41: differential exposure of the Kennedy epitope on cell and viral membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Atomic structure of a thermostable subdomain of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantially.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

European guidelines on the clinical management of HIV-1 tropism testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

A unique, naturally occurring single-amino acid mutation in HIV type 1 V3 loop can discriminate between its cytopathicity and replication in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Widespread adaptive evolution in the human immunodeficiency virus type 1 genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Molecular determinants of HIV-1 subtype C coreceptor transition from R5 to R5X4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIRUSRES.2012.06.019

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45229513&oldid=2070716488"